276 related articles for article (PubMed ID: 21856817)
1. Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension.
Chester M; Seedorf G; Tourneux P; Gien J; Tseng N; Grover T; Wright J; Stasch JP; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L755-64. PubMed ID: 21856817
[TBL] [Abstract][Full Text] [Related]
2. Cinaciguat, a soluble guanylate cyclase activator, causes potent and sustained pulmonary vasodilation in the ovine fetus.
Chester M; Tourneux P; Seedorf G; Grover TR; Gien J; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2009 Aug; 297(2):L318-25. PubMed ID: 19465519
[TBL] [Abstract][Full Text] [Related]
3. Hydrocortisone normalizes oxygenation and cGMP regulation in lambs with persistent pulmonary hypertension of the newborn.
Perez M; Lakshminrusimha S; Wedgwood S; Czech L; Gugino SF; Russell JA; Farrow KN; Steinhorn RH
Am J Physiol Lung Cell Mol Physiol; 2012 Mar; 302(6):L595-603. PubMed ID: 22198909
[TBL] [Abstract][Full Text] [Related]
4. Inhaled agonists of soluble guanylate cyclase induce selective pulmonary vasodilation.
Evgenov OV; Kohane DS; Bloch KD; Stasch JP; Volpato GP; Bellas E; Evgenov NV; Buys ES; Gnoth MJ; Graveline AR; Liu R; Hess DR; Langer R; Zapol WM
Am J Respir Crit Care Med; 2007 Dec; 176(11):1138-45. PubMed ID: 17872487
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary vascular effects of nitric oxide-cGMP augmentation in a model of chronic pulmonary hypertension in fetal and neonatal sheep.
Deruelle P; Grover TR; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2005 Nov; 289(5):L798-806. PubMed ID: 15964898
[TBL] [Abstract][Full Text] [Related]
6. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats.
Reinke Y; Gross S; Eckerle LG; Hertrich I; Busch M; Busch R; Riad A; Rauch BH; Stasch JP; Dörr M; Felix SB
Eur J Pharmacol; 2015 Nov; 767():1-9. PubMed ID: 26407652
[TBL] [Abstract][Full Text] [Related]
7. SOD and inhaled nitric oxide normalize phosphodiesterase 5 expression and activity in neonatal lambs with persistent pulmonary hypertension.
Farrow KN; Lakshminrusimha S; Czech L; Groh BS; Gugino SF; Davis JM; Russell JA; Steinhorn RH
Am J Physiol Lung Cell Mol Physiol; 2010 Jul; 299(1):L109-16. PubMed ID: 20400523
[TBL] [Abstract][Full Text] [Related]
8. Increased hydrogen peroxide downregulates soluble guanylate cyclase in the lungs of lambs with persistent pulmonary hypertension of the newborn.
Wedgwood S; Steinhorn RH; Bunderson M; Wilham J; Lakshminrusimha S; Brennan LA; Black SM
Am J Physiol Lung Cell Mol Physiol; 2005 Oct; 289(4):L660-6. PubMed ID: 15937064
[TBL] [Abstract][Full Text] [Related]
9. Altered guanylyl-cyclase activity in vitro of pulmonary arteries from fetal lambs with congenital diaphragmatic hernia.
Thébaud B; Petit T; De Lagausie P; Dall'Ava-Santucci J; Mercier JC; Dinh-Xuan AT
Am J Respir Cell Mol Biol; 2002 Jul; 27(1):42-7. PubMed ID: 12091244
[TBL] [Abstract][Full Text] [Related]
10. Effects of chronic hypoxia on soluble guanylate cyclase activity in fetal and adult ovine cerebral arteries.
Pearce WJ; Williams JM; White CR; Lincoln TM
J Appl Physiol (1985); 2009 Jul; 107(1):192-9. PubMed ID: 19407253
[TBL] [Abstract][Full Text] [Related]
11. Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation.
Nimmegeers S; Sips P; Buys E; Brouckaert P; Van de Voorde J
Cardiovasc Res; 2007 Oct; 76(1):149-59. PubMed ID: 17610859
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary and systemic vasodilator responses to the soluble guanylyl cyclase activator, BAY 60-2770, are not dependent on endogenous nitric oxide or reduced heme.
Pankey EA; Bhartiya M; Badejo AM; Haider U; Stasch JP; Murthy SN; Nossaman BD; Kadowitz PJ
Am J Physiol Heart Circ Physiol; 2011 Mar; 300(3):H792-802. PubMed ID: 21217076
[TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase 3A expression is modulated by nitric oxide in rat pulmonary artery smooth muscle cells.
Busch CJ; Graveline AR; Jiramongkolchai K; Liu H; Sanchez LS; Bloch KD
J Physiol Pharmacol; 2010 Dec; 61(6):663-9. PubMed ID: 21224496
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide- and heme-independent activation of soluble guanylate cyclase attenuates peroxynitrite-induced endothelial dysfunction in rat aorta.
Korkmaz S; Loganathan S; Mikles B; Radovits T; Barnucz E; Hirschberg K; Li S; Hegedüs P; Páli S; Weymann A; Karck M; Szabó G
J Cardiovasc Pharmacol Ther; 2013 Jan; 18(1):70-7. PubMed ID: 22914857
[TBL] [Abstract][Full Text] [Related]
15. Preserved activity of soluble guanylate cyclase (sGC) in iliac artery from middle-aged rats: Role of sGC modulators.
Justo AFO; de Oliveira MG; Calmasini FB; Alexandre EC; Bertollotto GM; Jacintho FF; Antunes E; Mónica FZ
Nitric Oxide; 2021 Jan; 106():9-16. PubMed ID: 33122152
[TBL] [Abstract][Full Text] [Related]
16. Responsiveness of rat aorta and pulmonary artery to cGMP generators in the presence of thiol or heme oxidant.
Tawa M; Yamashita Y; Masuoka T; Nakano K; Yoshida J; Nishio M; Ishibashi T
J Pharmacol Sci; 2019 May; 140(1):43-47. PubMed ID: 31036520
[TBL] [Abstract][Full Text] [Related]
17. The cGMP-specific phosphodiesterase inhibitor E4021 dilates the pulmonary circulation.
Dukarm RC; Russell JA; Morin FC; Perry BJ; Steinhorn RH
Am J Respir Crit Care Med; 1999 Sep; 160(3):858-65. PubMed ID: 10471609
[TBL] [Abstract][Full Text] [Related]
18. Effects of hydrogen peroxide on relaxation through the NO/sGC/cGMP pathway in isolated rat iliac arteries.
Tawa M; Shimosato T; Iwasaki H; Imamura T; Okamura T
Free Radic Res; 2015; 49(12):1479-87. PubMed ID: 26334090
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
Boerrigter G; Burnett JC
Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
[TBL] [Abstract][Full Text] [Related]
20. Irreversible Activation and Stabilization of Soluble Guanylate Cyclase by the Protoporphyrin IX Mimetic Cinaciguat.
Kollau A; Opelt M; Wölkart G; Gorren ACF; Russwurm M; Koesling D; Mayer B; Schrammel A
Mol Pharmacol; 2018 Feb; 93(2):73-78. PubMed ID: 29138269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
